Division of Biochemical Pharmacology, Department of Biology, University of Konstanz, Konstanz, Germany.
Institute of Preventive Veterinary Medicine, Sichuan Agricultural University, Sichuan, P.R. China.
Sci Adv. 2019 Jul 17;5(7):eaav9732. doi: 10.1126/sciadv.aav9732. eCollection 2019 Jul.
LRH-1 (liver receptor homolog-1/NR5a2) is an orphan nuclear receptor, which regulates glucose and lipid metabolism, as well as intestinal inflammation via the transcriptional control of intestinal glucocorticoid synthesis. Predominantly expressed in epithelial cells, its expression and role in immune cells are presently enigmatic. LRH-1 was found to be induced in immature and mature T lymphocytes upon stimulation. T cell-specific deletion of LRH-1 causes a drastic loss of mature peripheral T cells. LRH-1-depleted CD4 T cells exert strongly reduced activation-induced proliferation in vitro and in vivo and fail to mount immune responses against model antigens and to induce experimental intestinal inflammation. Similarly, LRH-1-deficient cytotoxic CD8 T cells fail to control viral infections. This study describes a novel and critical role of LRH-1 in T cell maturation, functions, and immopathologies and proposes LRH-1 as an emerging pharmacological target in the treatment of T cell-mediated inflammatory diseases.
LRH-1(肝受体同系物-1/NR5a2)是一种孤儿核受体,通过转录控制肠道糖皮质激素合成,调节葡萄糖和脂质代谢以及肠道炎症。它主要在肠上皮细胞中表达,但其在免疫细胞中的表达和作用目前仍是一个谜。研究发现,LRH-1 在刺激后的未成熟和成熟 T 淋巴细胞中被诱导。T 细胞特异性敲除 LRH-1 会导致成熟外周 T 细胞大量丧失。LRH-1 耗尽的 CD4 T 细胞在体外和体内的激活诱导增殖能力显著降低,无法对模型抗原产生免疫反应,也无法诱导实验性肠道炎症。同样,LRH-1 缺陷的细胞毒性 CD8 T 细胞也无法控制病毒感染。本研究描述了 LRH-1 在 T 细胞成熟、功能和免疫病理中的新的关键作用,并提出 LRH-1 是治疗 T 细胞介导的炎症性疾病的一个新兴的药理学靶点。